Celltrion Healthcare is committed to delivering innovative and affordable medications to promote patients’ access to advanced therapies. Its products are manufactured at state-of-the-art mammalian cell culture facilities, designed and built to comply with the United States Food and Drug Administration’s Current Good Manufacturing Practice (CGMP) regulations and the European Union’s good manufacturing practice (GMP) guidelines. Celltrion Healthcare endeavors to offer high-quality, cost-effective solutions through an extensive global network.
Celltrion USA is Celltrion Healthcare’s U.S. subsidiary established in 2018. Headquartered in New Jersey, Celltrion USA is committed to expanding access to biologics to improve care for U.S. patients. Celltrion USA will continue to leverage Celltrion Healthcare’s unique heritage in biotechnology, supply chain excellence, and best-in-class sales capabilities to improve access to high-quality biopharmaceuticals for U.S. patients.
Celltrion is a combination of the terms “cell” in our body and “Triones,” a guiding star that is also known as the Big Dipper. The name of our company conveys our will to promote the health and welfare of humanity by becoming a “guiding star” in the bio industry. We, Celltrion USA will work hard to achieve our dream of “rewriting the bio-history.” We will exert all efforts to create a richer and healthier future for humanity that emphasizes the significance of coexistence and prosperity.